News Feb 3, 2025 Alimentiv and PhaseV Partner on Machine Learning-Based Solutions to Tackle Challenges in GI Clinical Trials February 3, 2025 – Alimentiv Inc., a global full-service GI Contract Research Organization (CRO), announced today it has entered a strategic partnership with PhaseV, a... Read Now
Article Feb 3, 2025 Connecting the Spots: How Histopathology Expertise Supports Spatial Transcriptomics Analysis The path to drug development is inherently complex. In preclinical stages of drug development, it is difficult to predict how a drug affects the heterogenous... Read Now
Article Dec 20, 2024 Advancing EoE Histopathology With Emerging AI Solutions From Alimentiv Disclaimer*The AI-based algorithm for automated PEC developed by Alimentiv is not a medical device and is not used by healthcare professionals for clinical diagnosis or... Read Now